{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:19:21Z","timestamp":1791497961093,"version":"4.3.4"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T00:00:00Z","timestamp":1172620800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0000260","type":"journal-article","created":{"date-parts":[[2007,2,27]],"date-time":"2007-02-27T22:31:37Z","timestamp":1172615497000},"page":"e260","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":87,"title":["PPAR\u03b1 Deficiency in Inflammatory Cells Suppresses Tumor Growth"],"prefix":"10.1371","volume":"2","author":[{"given":"Arja","family":"Kaipainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Kieran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Bielenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Mostoslavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judah","family":"Folkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Panigrahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2007,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression.","volume":"432","author":"NA Bhowmick","year":"2004","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1038\/sj.bjc.6601705","article-title":"Role of infiltrated leucocytes in tumour growth and spread.","volume":"90","author":"EY Lin","year":"2004","journal-title":"Br J Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development.","volume":"6","author":"KE de Visser","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.molmed.2005.03.002","article-title":"Immunotherapy: target the stroma to hit the tumor.","volume":"11","author":"T Kammertoens","year":"2005","journal-title":"Trends Mol Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.","volume":"348","author":"L Zhang","year":"2003","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","article-title":"NF-kappaB functions as a tumour promoter in inflammation-associated cancer.","volume":"431","author":"E Pikarsky","year":"2004","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","article-title":"Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.","volume":"393","author":"B Staels","year":"1998","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/384039a0","article-title":"The PPARalpha-leukotriene B4 pathway to inflammation control.","volume":"384","author":"PR Devchand","year":"1996","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0303-7207(02)00098-9","article-title":"The peroxisome proliferator-activated receptor alpha (PPARalpha): role in hepatocarcinogenesis.","volume":"193","author":"FJ Gonzalez","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/carcin\/18.11.2029","article-title":"Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.","volume":"18","author":"JM Peters","year":"1997","journal-title":"Carcinogenesis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/carcin\/bgh285","article-title":"Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.","volume":"26","author":"T Hays","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref12","first-page":"3241","article-title":"Peroxisome proliferator-activated receptor \u03b1 is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma.","volume":"6","author":"GP Collett","year":"2000","journal-title":"Clin Canc Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/1098-2744(200011)29:3<134::AID-MC2>3.0.CO;2-F","article-title":"Activators of peroxisome proliferator-activated-\u03b1 partially inhibit mouse skin tumor promotion.","volume":"29","author":"P Thuillier","year":"2000","journal-title":"Mol Carcinog"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1083\/jcb.200011148","article-title":"Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice.","volume":"154","author":"L Michalik","year":"2001","journal-title":"J Cell Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI11497","article-title":"PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice.","volume":"107","author":"K Tordjman","year":"2001","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","article-title":"Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.","volume":"88","author":"M Serrano","year":"1997","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/44334","article-title":"Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.","volume":"401","author":"D Lyden","year":"1999","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/jnci\/93.14.1075","article-title":"Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for &quot;no take&quot; of human tumors in mice.","volume":"93","author":"EG Achilles","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1096\/fj.01-0813com","article-title":"Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy.","volume":"16","author":"T Udagawa","year":"2002","journal-title":"Faseb J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1073\/pnas.0404272101","article-title":"Dose-dependent response of FGF-2 for lymphangiogenesis.","volume":"101","author":"LK Chang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1083\/jcb.141.7.1659","article-title":"Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis.","volume":"141","author":"G Seghezzi","year":"1998","journal-title":"J Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1113\/jphysiol.1952.sp004789","article-title":"Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs.","volume":"118","author":"AA Miles","year":"1952","journal-title":"J Physiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.","volume":"20","author":"HF Dvorak","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer.","volume":"420","author":"LM Coussens","year":"2002","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccr.2004.09.028","article-title":"Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis.","volume":"6","author":"A Sparmann","year":"2004","journal-title":"Cancer Cell"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.07.013","article-title":"IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.","volume":"118","author":"FR Greten","year":"2004","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1.","volume":"274","author":"P Delerive","year":"1999","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1083\/jcb.111.6.3077","article-title":"Thrombospondin stimulates motility of human neutrophils.","volume":"111","author":"PJ Mansfield","year":"1990","journal-title":"J Cell Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-03-3126","article-title":"Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression.","volume":"64","author":"Y Hamano","year":"2004","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.biocel.2004.01.008","article-title":"Tumor progression: the effects of thrombospondin-1 and -2.","volume":"36","author":"J Lawler","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"Mechanism of action of PPARs.","volume":"53","author":"J Berger","year":"2002","journal-title":"Ann Rev Med"},{"key":"ref32","first-page":"2424","article-title":"Ligands for peroxisome proliferator-activated receptors \u03b1 and \u03b3 inhibit chemically induced colitis and formation of aberrant crypt foci in rats.","volume":"61","author":"T Tanaka","year":"2001","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0006-2952(00)00430-5","article-title":"Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis.","volume":"60","author":"BP Neve","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI10370","article-title":"Peroxisome proliferator-activated receptor \u03b3 ligands inhibit development of atheroclerosis in LDL receptor-deficient mice.","volume":"106","author":"AC Li","year":"2000","journal-title":"J Clin Invest"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1747.2000.00073.x","article-title":"Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo.","volume":"115","author":"LG Komuves","year":"2000","journal-title":"J Invest Dermatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2002.35276","article-title":"Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice.","volume":"36","author":"SP Anderson","year":"2002","journal-title":"Hepatology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","article-title":"Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.","volume":"15","author":"SS Lee","year":"1995","journal-title":"Mol Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/rtph.1997.1163","article-title":"Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?","volume":"27","author":"RC Cattley","year":"1998","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI12749","article-title":"Thrombospondins as matricellular modulators of cell function.","volume":"107","author":"P Bornstein","year":"2001","journal-title":"J Clin Invest"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1471-4914(01)02102-5","article-title":"Thrombospondins and tumor angiogenesis.","volume":"7","author":"F de Fraipont","year":"2001","journal-title":"Trends Mol Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1083\/jcb.200407060","article-title":"Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins.","volume":"168","author":"SM Short","year":"2005","journal-title":"J Cell Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jss.2004.05.015","article-title":"The role of thrombospondin-1 in human disease.","volume":"122","author":"N Esemuede","year":"2004","journal-title":"J Surg Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1083\/jcb.107.6.2351","article-title":"Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.","volume":"107","author":"J Lawler","year":"1988","journal-title":"J Cell Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-9440(10)65140-1","article-title":"Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas.","volume":"155","author":"M Streit","year":"1999","journal-title":"Am J Pathol"},{"key":"ref45","first-page":"6504","article-title":"Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.","volume":"54","author":"DL Weinstat-Saslow","year":"1994","journal-title":"Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0039-6060(96)80322-9","article-title":"Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor.","volume":"120","author":"TN Wang","year":"1996","journal-title":"Surgery"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0046-8177(98)90410-5","article-title":"Rapid growth of cutaneous metastases after surgical resection of thrombospondin-secreting small blue round cell tumor of childhood.","volume":"29","author":"SE Crawford","year":"1998","journal-title":"Hum Pathol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/jsre.1996.0219","article-title":"Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer.","volume":"63","author":"TN Wang","year":"1996","journal-title":"J Surg Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/jsre.1998.5299","article-title":"The effect of thrombospondin-1 and TGF-beta 1 on pancreatic cancer cell invasion.","volume":"76","author":"D Albo","year":"1998","journal-title":"J Surg Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0038-1648509","article-title":"Thrombospondin levels in patients with malignancy.","volume":"67","author":"GP Tuszynski","year":"1992","journal-title":"Thromb Haemost"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/1097-0142(19940601)73:11<2853::AID-CNCR2820731131>3.0.CO;2-9","article-title":"Plasma thrombospondin levels in patients with gynecologic malignancies.","volume":"73","author":"FE Nathan","year":"1994","journal-title":"Cancer"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<632::AID-CNCR3>3.0.CO;2-N","article-title":"Plasma thrombospondin levels in patients with colorectal carcinoma.","volume":"82","author":"Y Yamashita","year":"1998","journal-title":"Cancer"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jnci\/89.3.219","article-title":"Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression.","volume":"89","author":"GD Grossfeld","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2570::AID-CNCR12>3.0.CO;2-F","article-title":"Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.","volume":"85","author":"Y Ohta","year":"1999","journal-title":"Cancer"},{"key":"ref55","first-page":"81","article-title":"Independent association of angiogenesis index with outcome in prostate cancer.","volume":"7","author":"R Mehta","year":"2001","journal-title":"Clin Cancer Res"},{"key":"ref56","first-page":"4375","article-title":"Stromal thrombospondin-1 expression is correlated with progression of esophageal squamous cell carcinomas.","volume":"19","author":"G Oshiba","year":"1999","journal-title":"Anticancer Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1023687505139","article-title":"Evidence of a bi-phasic effect of thrombospondin-1 on angiogenesis.","volume":"34","author":"K Motegi","year":"2002","journal-title":"Histochem J"},{"key":"ref58","first-page":"2726","article-title":"Interferon-\u03b1-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.","volume":"5","author":"JW Slaton","year":"1999","journal-title":"Clin Cancer Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0215634","article-title":"PPAR\u03b3 ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis.","volume":"110","author":"D Panigrahy","year":"2002","journal-title":"J Clin Invest"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"11044","DOI":"10.1158\/0008-5472.CAN-05-2617","article-title":"Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve.","volume":"65","author":"I Celik","year":"2005","journal-title":"Cancer Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.embor.embor953","article-title":"What doesn&apos;t kill you makes you stronger. A new model for risk assessment may not only revolutionize the field of toxicology, but also have vast implications for risk assessment.","volume":"4","author":"C Hadley","year":"2003","journal-title":"EMBO Rep"},{"key":"ref62","article-title":"Endostatin therapy reveals a U-shaped curve for antitumor activity.","author":"RM Tjin Tham Sjin","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"ref63","first-page":"125","article-title":"Immunogenicity.","author":"DJA Crommelin","year":"2002"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.","volume":"351","author":"SS Dave","year":"2004","journal-title":"N Engl J Med"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"29577","DOI":"10.1074\/jbc.273.45.29577","article-title":"Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis.","volume":"273","author":"P Costet","year":"1998","journal-title":"J Biol Chem"},{"key":"ref66","first-page":"1625","article-title":"A model of angiogenesis in the mouse cornea.","volume":"37","author":"BM Kenyon","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9440(10)64869-9","article-title":"Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.","volume":"160","author":"AM Joussen","year":"2002","journal-title":"Am J Pathol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0000260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T23:58:18Z","timestamp":1556150298000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0000260"}},"subtitle":[],"editor":[{"given":"Mikhail","family":"Blagosklonny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,2,28]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0000260","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,28]]}}}